Is OEM or ODM service available?

Yes, both OEM and ODM services are available for this product.

How should the product be stored?

It should be preserved in tight, light-resistant containers in a cool place.

What is the molecular weight of Naltrexone HCl?

The molecular weight is 371.42.

99% Raw Material Naltrexone Hydrochloride (Naltrexone HCl) CAS 16676-29-2 Pharmaceutical Powder

Name: 99% Raw Material Naltrexone Hydrochloride (Naltrexone HCl) CAS 16676-29-2 Pharmaceutical Powder
Brand: Beijing Mesochem Technology Co., Ltd.
SKU: 910948415

Beijing, ChinaBeijing Mesochem Technology Co., Ltd.

US$10.00-100.00

1 g

Sample price:US$100.00/g.Request sample

Product profile

Customization

Available

Function

Antineoplastic, Chemical Medicine Raw Materal

Certification

GMP, USP, Ep, Bp

Model NO.

16676-29-2

Grade Standard

Medicine Grade

Type

Chemical Medicine Raw Materal

State

Powder

Volatile

Not Volatile

Name

Naltrexone Hydrochloride

CAS Registry Number

16676-29-2

Molecular Formula

C16h17n7o2s

Molecular Weight

371.42

Transport Package

10kg/Barrel

Specification

GMP

Trademark

Mesochem

Origin

China

HS Code

2934999090

Production Capacity

G/Kg

Key features

High Purity Assay: Assay results reach 99.94%, exceeding the standard range of 98.0%-102.0%.

Multiple Certifications: Certified with GMP, USP, Ep, and Bp standards for pharmaceutical quality.

Custom Packaging: Packaging is available as required by the customer, ensuring flexibility.

OEM/ODM Service: ODM and OEM services are available for customized product needs.

Strict Quality Control: Complies with in-house standards for impurities, heavy metals, and water content.

Fast Lead Time: Average lead time is one month for both peak and off-season periods.

Global Export Experience: Exporting since 2010 to North America, Europe, Asia, and other regions.

Professional Manufacturer: Established in 2009 with 35 employees and independent import/export rights.

Company profile

Beijing Mesochem Technology Co., Ltd.

Beijing, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2010-04-01 CertifiedNearest Port: Tianjin PortAverage Response Time: ≤3.00h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryBeijing Mesochem Technology Co., Ltd. is a China-based limited company established in 2009, with 35 employees and reported operations in health, medicine, and chemicals. The supplied information describes two production bases with approximately 67,000 m² of production area and 30,000 L of manufacturing equipment, while another record lists an 800 m² manufacturing plant; this discrepancy should be verified. The supplier reports more than 10 production lines, 6–10 quality-control staff, R&D, pilot, and commercial production capabilities, and product capacity information for several pharmaceutical compounds. It holds ISO 9001:2015 certification and states that its quality system is aligned with FDA, ICH, and EDQM requirements, although FDA review status is not equivalent to approval. Export sales account for 71%–90% of total sales, and three individual trade records identify Everest Pharmaceuticals Limited as a buyer in Bangladesh. Evidence is insufficient to assess after-sales service, customization, and...

Supplier typeThe supplier is identified as a China-based limited company with a combined business-entity type, while one record classifies its company nature as a trading company. Its stated commercial areas include health and medicine and chemicals, and it also reports production bases and manufacturing capabilities, indicating a mixed trading and manufacturing profile.

CertificationsThe supplier reports holding an ISO 9001:2015 certificate and states that its quality assurance system is established to meet FDA, ICH, and EDQM requirements. The slices do not provide certificate scope, validity dates, or evidence of FDA approval, but the stated ISO certification is explicit.

R&D capabilityThe supplier states that it has R&D, pilot-production, and commercial-production capabilities, and reports two ANDAs under FDA review, with more than ten formulations submitted for marketing authorization in multiple regulatory markets. Three R&D engineers are reported, supporting demonstrated development activity, although the depth and success of the innovation program are not fully documented.

Production capacityThe supplier reports two production bases, approximately 67,000 m² of production area, about 30,000 L of equipment, more than 10 production lines, and 6–10 quality-control staff. It also provides product-specific annual productivity entries for adapalene, pimavanserin tartrate, tenofovir alafenamide fumarate, tofacitinib citrate, and lorcaserin hydrochloride. However, the separate 800 m² plant-area record conflicts with the 67,000 m² figure and requires verification.

Client casesThree trade records identify Everest Pharmaceuticals Limited as a buyer for finerenone, velpatasvir, and olaparib, each associated with Bangladesh and one recorded transaction. These records provide concrete customer and product examples, but the limited transaction count does not demonstrate a broad or long-term customer portfolio.